Loading clinical trials...
Loading clinical trials...
The assumption has been that 1,25(OH)2D is solely responsible for calcium absorption. That has been one of the presumed causes of hyperparathyroidism in chronic kidney disease (CKD) (low 1,25(OH)2D le...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Creighton University
Collaborators
NCT06474169 · Chronic Kidney Diseases
NCT07194590 · Chronic Kidney Disease (Stage 3-4), Vascular Function, and more
NCT06422871 · End Stage Renal Disease, Hemodialysis Access Failure
NCT07593352 · IBD and Renal Involement, Chronic Kidney Disease, and more
NCT07481526 · Chronic Kidney Disease
Creighton University
Omaha, Nebraska
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions